Cyclopharm Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was AUD 26.34 million compared to AUD 22.88 million a year ago. Revenue was AUD 32.21 million compared to AUD 24.96 million a year ago.

Net loss was AUD 4.7 million compared to AUD 6.61 million a year ago. Basic loss per share from continuing operations was AUD 0.0507 compared to AUD 0.0717 a year ago. Diluted loss per share from continuing operations was AUD 0.0507 compared to AUD 0.0717 a year ago.